Umbipro H-W-3799

  • Email
  • Help
Name of the medicinal product

Umbipro

Opinion holderGlaxoSmithKline Trading Services
Currabinny
Cork
Ireland
Active substance

Chlorhexidine digluconate

International non-proprietary name or common nameChlorhexidine
Pharmaco-therapeutic group

Antiseptics and disinfectants, biguanides and amidines

ATC codeD08AC02
Therapeutic indication

Umbipro is indicated for prophylaxis of omphalitis (infection of the umbilical cord) in newborn infants.

Orphan medicinal product designation dateNot applicable

Back to top

Document(s) Language Status First published Last updated Effective Date
Umbipro : Summary for the public (English only)   2016-07-01    
Umbipro : All authorised presentations (English only)   2016-07-01    
Umbipro : Assessment report (English only)   2016-07-01    
CHMP summary of positive opinion for Umbipro (English only) adopted 2016-04-29    

Product Information* 28/04/2016 Umbipro -H-W-3799

Back to top

Document(s) Language Status First published Last updated Effective Date
Umbipro : Product information (English only)   2016-07-01    

Related links

*This document includes:

Annex I - Summary of product characteristics
Annex IIA - Manufacturer responsible for batch release
Annex IIB - Recommendations to the opinion holder - conditions of use
Annex IIIA - Labelling
Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.